Company intelligence / Profile preview
Axikin Pharmaceuticals, Inc.
San Diego, California, United Statesbiospace.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Preclinical
01
Overview
Completed a Phase 2a randomized double-blind placebo-controlled trial (NCT01890161) evaluating AXP1275 on asthmatic response to pulmonary allergen challenge in adults with mild-to-moderate atopic asthma
- Therapeutic areas
- GastroenterologyPulmonologyDermatologyImmunology
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Spun out from Actimis Pharmaceuticals following acquisition by Boehringer Ingelheim
Beyond the preview
Go deeper on Axikin Pharmaceuticals, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Axikin Pharmaceuticals, Inc..